Tablets 2.3

Updated October 6, 2026

Overview

Product sourcing insights & recommendations

25 来源

The phrase "tablets 2.3" is not a singular product but appears most prominently in two distinct commercial contexts: Veterinary Pharmaceuticals and Display Technology Forecasts.

1. Product Grounding: "Tablets 2.3 mg" (Veterinary)

In the product space, "2.3 mg tablets" most commonly refers to a specific dosage of veterinary medication for small pets:

* Program Plus (2.3 mg / 46 mg): A film-coated combination tablet used for small dogs (1–4.5 kg). It contains 2.3 mg of Milbemycin Oxime (for heartworm/worms) and 46 mg of Lufenuron (for flea control) Defra Federalregister.

* Market Status: The specific authorization for this product in certain regions (e.g., UK) expired in January 2023, making it a "legacy" dosage that may be transitioning to newer formulations or generic alternatives in the 2026 market Defra.

2. Market Trend: "-2.3% YoY OLED Tablet Shipments" (Consumer Tech)

In the 2025–2026 consumer electronics landscape, "2.3" appears as a critical market signal:

* OLED Panel Forecast: Tablet OLED panel shipments are forecast to decrease by 2.3% YoY in 2025 relative to previous aggressive growth targets Informa.

* Trend Insight: Despite this slight downward adjustment in shipment *volume*, the market is seeing a massive 190% YoY increase in *large-area OLED* shipments overall, driven by high-end tablets (like the iPad Pro) adopting "Tandem OLED" technology to replace older LCD/Mini-LED standards.

3. Legacy Tech: Android 2.3 "Gingerbread"

"Tablets 2.3" may also refer to devices running the Android 2.3 (Gingerbread) operating system:

* Status: These are considered "obsolete" or "retro" devices in 2026. While modern B2B suppliers focus on Android 13-15 Facebook, Android 2.3 tablets like the Polaroid PMID701C remain points of interest in secondary markets for specialized legacy applications or hobbyist restoration Youtube Instagram.

The term 'tablets 2.3' primarily relates to veterinary pharmaceuticals or market forecasts. How would you like to proceed?

Sources & References

25 sources cited · Verified industry data & reports

AURO-CLADRIBINE (Cladribine Tablets) Product Monograph ...

hres.ca

1 INDICATIONS. AURO-CLADRIBINE (cladribine tablets) is indicated as monotherapy for the treatment of adult.

China Android 2.3 Tablet Laptop

Made-in-China.com

MID-812 (Tablet PC, 8 inch Capacitive 5 points touch + Android 2.3 + WiFi). Negotiable. 500 Pieces (MOQ). Danyang Yikai Electrons & Tools ...

Product Information Database - Veterinary Medicines Directorate

GOV.UK

Product Details. Program Plus Film-coated Tablets 2.3 mg/46 mg. MA holder: Elanco Europe Ltd. VM number: 00879/4029. Previous VM Numbers.

Oral Dosage Form New Animal Drugs; Lufenuron Tablets ...

Federal Register (.gov)

Milbemycin oxime and lufenuron tablets. (a) Specifications —(1) Tablets containing: 2.3 milligrams (mg) milbemycin oxime and 46 mg lufenuron ...

Label: LEVOTHYROXINE SODIUM tablet - DailyMed

DailyMed (.gov)

WARNING: NOT FOR TREATMENT OF OBESITY OR FOR WEIGHT LOSS. Thyroid hormones, including levothyroxine sodium tablets, either alone or with other therapeutic ...

Evaluation of chitosan–anionic polymers based tablets for ...

ScienceDirect.com

The objective of this study is to develop chitosan–anionic polymers based extended-release tablets and test the feasibility of using this system for the ...